Breaking News
Jake Paul - Trump interview: We cover the Iran war, immigration policies, the assassination...
US Attorney Jeanine Pirro just announced activist Judge Boasberg has BLOCKED a Grand Jury...
Cost of the Iran War--and Why It Will Fuel Inflation
Senator Ted Cruz Says "Christ Is King" Means "I Hate The Jews" & Jews, Not Chris
Top Tech News
Human Brain Cells Merge With Silica To Play DOOM
Will Yann LeCun Provide The Next Breakthrough In AI?
Human Brain Cells Merge With Silica To Play DOOM
Solar And Storage Could Reshape Rural Electricity Markets
With World Seemingly At War, DARPA Finds Time To Unveil The X-76
Renewable Water From Air.
The world's first diesel plug-in hybrid pickup truck is here
US advances nuclear revival with approval of Natrium Gen IV reactor
Your Contractor Doesn't Want Me To Show You This!
CEO of Blacklisted AI Company Anthropic, Dario Amodei Says His AI Models 'May Have Gained...
'TUMOUR KILLER' Cancer patients 'CURED' after doctors turbocharge their blood's
Two adults with leukaemia have been in remission since 2010 after Car-T therapy.
It involves removing blood and genetically modifying its white cells so they target cancer.
The resulting Car-T cells are re-injected in a type of immunotherapy which uses the body's immune system to attack tumours.
Levels of the cells in the two cured patients remain high.
Dr Carl June, of the University of Pennsylvania, US, said: "Based on these results, we can conclude that Car-T cells can cure leukaemia.
"These cells continued to demonstrate tumour-killing characteristics."
Patient Doug Olsen said medics could not find any cancer after a few weeks. He said: "I knew the doctors weren't sure but I was pretty convinced that I was done with cancer."
The NHS offers Car-T to some children with leukaemia and adults with lymphoma.
It warns the therapy can make the immune system over-react or trigger side effects such as fever, vomiting or breathing difficulties.